Fenucure Medical ApS: Financial statements 2018
CVR: 28486871
Source: annual report 2018, Danish Business Authority
01/07/2017 – 30/06/2018
Fenucure Medical ApS (CVR 28486871) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -608,212 and a net result of DKK -87,579 compared with DKK -2,164,303 the year before. Equity in the 2018 report amounted to DKK 2,441,120. The solvency ratio was 95.1%.
- Gross Profit
- DKK -608,212
- Profit/Loss
- DKK -87,579
- Equity
- DKK 2,441,120
- Total Assets
- DKK 2,568,085
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -608K | -88K | 2.4M | - |
| 2017 | - | -1.6M | -2.2M | 121K | 1 |
| 2016 | 200K | -1.7M | -1.8M | -3.2M | - |
| 2015 | 1.2M | -723K | -1.1M | -1.3M | - |
| 2014 | - | -10K | -26K | -178K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of November 15, 2018, Philip Xavier Severin Møller has stepped down as director of Fenucure Medical ApS.
About Fenucure Medical ApS
Fenucure Medical ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2005. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named V-BIOTEK ApS and VIND INVEST ApS. The management consists of Christian Hother Sørensen. The board consists of Nicolai Fink Gundersen (chair), Alex Gundersen, Mogens Viktor Madsen and Niels Christian Beck Vase. The company is owned by V-BIOTEK HOLDING ApS, Redwood Foundation ApS and Alex Gundersen Assens ApS. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK -1,214,608 and a net result of DKK -3,201,378 compared with DKK -1,529,007 the year before. Equity in the 2025 report amounted to DKK 593,861.